Journal

Clinical cardiology

Publication Date

7-1-2020

Volume

43

Issue

7

First Page

743

Last Page

751

Document Type

Open Access Publication

DOI

10.1002/clc.23376

clc23376-sup-0001-figures1.pdf (59 kB)
Figure S1 Switching from Warfarin to DOAC Stratified by CHA2DS2‐VASc Score Tertiles

clc23376-sup-0002-figures2.pdf (68 kB)
Figure S2 Univariate Hierarchical Regression Model with CHA2DS2‐VASc Score Only

clc23376-sup-0003-figures3.pdf (167 kB)
Figure S3 Predictors of Switching from Warfarin to DOACs (with Covariates of the CHA2DS2‐VASc Score)

clc23376-sup-0004-figures4.pdf (127 kB)
Figure S4 Multiple Anticoagulation Switches Flow Chart

clc23376-sup-0005-tables1.pdf (97 kB)
Table S1 Patient Characteristics, Entire Population Initially Managed on Warfarin

clc23376-sup-0006-tables2.pdf (120 kB)
Table S2 Patient Characteristics ‐ Switched to DOAC vs Not Switched

clc23376-sup-0007-tables3.pdf (146 kB)
Table S3 Patients Characteristics ‐ by Switching Cohorts

clc23376-sup-0008-tables4.pdf (63 kB)
Table S4 Practice Characteristics ‐ All Analysis Population

clc23376-sup-0009-tables5.pdf (55 kB)
Table S5 Switching from Warfarin to DOAC by Time Period

clc23376-sup-0010-tables6.pdf (53 kB)
Table S6 Time from Initial Visit to First Switch

Share

COinS